Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
CALL
Neurocrine Biosciences
NBIX
$15.6B
| $14.3M | 0.03% |
+300,000
| New | +$12.7M |
|
777
Mid-America Apartment Communities
MAA
$15.4B
| $14.3M | 0.03% |
196,451
+26,904
| +16% | +$2.03M |
|
778
Alcoa
AA
$13B
| $14.3M | 0.03% |
532,793
-794,256
| -60% | -$24.6M |
|
779
Glacier Bancorp
GBCI
$6.09B
| $14.2M | 0.03% |
481,462
-1,218,160
| -72% | -$33.4M |
|
|
KKD
780
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
| $14.1M | 0.03% |
+733,369
| New | +$13.6M |
|
781
Civeo
CVEO
$348M
| $14.1M | 0.03% |
382,799
+319,354
| +503% | +$14.4M |
|
782
John Wiley & Sons Class A
WLY
$2.7B
| $14.1M | 0.03% |
259,327
+95,412
| +58% | +$5.54M |
|
|
TTPH
783
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $14.1M | 0.03% |
14,859
+2,778
| +23% | +$2.27M |
|
784
Broadridge
BR
$21.1B
| $14.1M | 0.03% |
281,854
+242,706
| +620% | +$12.9M |
|
|
AAMI
785
Acadian Asset Management
AAMI
$3.26B
| $14.1M | 0.03% |
792,192
+435,133
| +122% | +$8.25M |
|
786
PTC Therapeutics
PTCT
$5.93B
| $14M | 0.03% |
+291,441
| New | +$17M |
|
|
EXPR
787
DELISTED
Express, Inc.
EXPR
| $14M | 0.03% |
38,625
-14,979
| -28% | -$5.23M |
|
788
Brixmor Property Group
BRX
$9.08B
| $14M | 0.03% |
604,683
-3,618,198
| -86% | -$88.2M |
|
789
Celldex Therapeutics
CLDX
$3.19B
| $14M | 0.03% |
36,898
-101,133
| -73% | -$40.2M |
|
|
VIAB
790
DELISTED
Viacom Inc. Class B
VIAB
| $13.9M | 0.03% |
215,690
+72,711
| +51% | +$4.92M |
|
|
NPKI
791
NPK International
NPKI
$1.12B
| $13.9M | 0.03% |
1,710,777
-1,452,979
| -46% | -$13.5M |
|
|
CBM
792
DELISTED
Cambrex Corporation
CBM
| $13.9M | 0.03% |
316,460
-250,479
| -44% | -$10.4M |
|
793
American Water Works
AWK
$27.8B
| $13.9M | 0.03% |
285,715
+214,055
| +299% | +$11.3M |
|
|
VAL
794
DELISTED
Valspar
VAL
| $13.9M | 0.03% |
169,784
-487,448
| -74% | -$40.9M |
|
795
Mattel
MAT
$4.23B
| $13.9M | 0.03% |
539,446
-2,434,627
| -82% | -$64.1M |
|
796
PUT
DNOW Inc
DNOW
$2.8B
| $13.8M | 0.03% |
694,100
-129,300
| -16% | -$2.96M |
|
|
797
Valero Energy
VLO
$99.6B
| $13.8M | 0.03% |
220,581
-3,169,902
| -93% | -$187M |
|
798
James River Group Holdings
JRVR
$190M
| $13.8M | 0.03% |
533,200
-140,579
| -21% | -$3.37M |
|
|
ACOR
799
DELISTED
Acorda Therapeutics
ACOR
| $13.8M | 0.03% |
3,445
-3,631
| -51% | -$14M |
|
800
Vanda Pharmaceuticals
VNDA
$322M
| $13.8M | 0.03% |
1,083,759
-515,403
| -32% | -$5.56M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.